Physician
Manuel J Sanchez, MD, PA
Manuel J Sanchez, MD, PA was paid $919K by Medicaid between Jan 2018 and Jan 2024, across 80 billing codes. Its largest line is 99444, — 58% of everything it billed.
33Billing provider infoMANUEL J SANCHEZ, MD, PA
MCALLEN, TX 78501
MCALLEN, TX 78501
33aNPI1295861557assigned 02/23/2007
33bProvider typeFamily Medicine Physician
28Total paid$919K
24GClaims82,558
24DCodes billed80
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#108 of 1,204
Median peer was paid$31K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,970 | $284K | |
| 2019 | 24,376 | $365K | |
| 2020 | 9,306 | $95K | |
| 2021 | 8,824 | $78K | |
| 2022 | 8,356 | $67K | |
| 2023 | 2,678 | $29K | |
| 2024incomplete | 48 | $595.77 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99444 | 58% | 9,350 | 2,399 | $534K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 7,808 | 6,288 | $135K |
| 99421 | 8.9% | 4,696 | 1,283 | $82K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 4.1% | 2,359 | 739 | $38K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.1% | 1,266 | 1,160 | $19K |
| 80050 | General health panel | 1.2% | 448 | 392 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 1,432 | 1,286 | $10K |
| 27370 | <1% | 2,009 | 610 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,451 | 1,285 | $9K |
| 77002 | <1% | 1,174 | 752 | $7K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,627 | 1,131 | $6K |
| 80061 | Lipid panel | <1% | 1,550 | 1,496 | $4K |
68 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,670 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 469 | $4K |
| 99000 | <1% | 1,074 | $3K | |
| 82044 | <1% | 1,933 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,140 | $3K |
| 97162 | <1% | 168 | $3K | |
| 82570 | <1% | 1,888 | $3K | |
| 20610 | <1% | 1,333 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,143 | $3K |
| 27369 | <1% | 1,009 | $3K | |
| 84439 | <1% | 1,189 | $2K | |
| 81001 | <1% | 2,648 | $2K | |
| 84481 | <1% | 998 | $2K | |
| 73580 | <1% | 3,032 | $2K | |
| 93000 | <1% | 394 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 118 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,461 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 228 | $1K |
| 90674 | <1% | 295 | $934.67 | |
| 99457 | <1% | 1,078 | $868.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 537 | $795.01 |
| 95923 | <1% | 27 | $748.08 | |
| 97032 | <1% | 2,275 | $646.13 | |
| 73560 | <1% | 309 | $586.78 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 82 | $561.06 |
| 99441 | <1% | 41 | $474.43 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 637 | $457.94 |
| 90756 | <1% | 26 | $446.82 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,234 | $356.07 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 552 | $255.38 |
| 90688 | <1% | 34 | $190.56 | |
| 99458 | <1% | 163 | $156.45 | |
| 99454 | <1% | 406 | $139.07 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 544 | $93.80 |
| 72082 | <1% | 16 | $60.52 | |
| 95921 | <1% | 27 | $59.94 | |
| 99453 | <1% | 15 | $36.10 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,113 | $31.62 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $28.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,845 | $16.00 |
| 84550 | <1% | 41 | $7.36 | |
| 85651 | <1% | 63 | $6.90 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,324 | $0.36 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 618 | $0.14 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 295 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 241 | $0.00 |
| 1170F | 0% | 321 | $0.00 | |
| 3074F | 0% | 13 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 257 | $0.00 |
| 1126F | 0% | 220 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 48 | $0.00 |
| 97016 | 0% | 45 | $0.00 | |
| 1125F | 0% | 17 | $0.00 | |
| 1090F | 0% | 308 | $0.00 | |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 0% | 983 | $0.00 |
| 3725F | 0% | 306 | $0.00 | |
| 1160F | 0% | 40 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 132 | $0.00 |
| 3288F | 0% | 297 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 133 | $0.00 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 308 | $0.00 |
| 77080 | 0% | 29 | $0.00 | |
| 82274 | 0% | 12 | $0.00 | |
| 1159F | 0% | 40 | $0.00 | |
| 99497 | 0% | 13 | $0.00 | |
| 96102 | 0% | 38 | $0.00 | |
| 3078F | 0% | 22 | $0.00 | |
| Q9960 | High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANCHEZ, MANUEL (OWNER)